标题
Molecular biology of neuroendocrine tumors: from pathways to biomarkers and targets
作者
关键词
Neuroendocrine tumors, Biomarker, Chromogranin A
出版物
CANCER AND METASTASIS REVIEWS
Volume 33, Issue 1, Pages 345-351
出版商
Springer Nature
发表日期
2013-12-27
DOI
10.1007/s10555-013-9468-y
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Molecular Pathogenesis of Neuroendocrine Tumors: Implications for Current and Future Therapeutic Approaches
- (2013) K. Oberg et al. CLINICAL CANCER RESEARCH
- Global microRNA profiling of well-differentiated small intestinal neuroendocrine tumors
- (2013) Su-Chen Li et al. MODERN PATHOLOGY
- Limitations of Chromogranin A in clinical practice
- (2012) Vincenzo Marotta et al. BIOMARKERS
- Prospective Study of Bevacizumab Plus Temozolomide in Patients With Advanced Neuroendocrine Tumors
- (2012) Jennifer A. Chan et al. JOURNAL OF CLINICAL ONCOLOGY
- Circulating Tumor Cells As Prognostic Markers in Neuroendocrine Tumors
- (2012) Mohid S. Khan et al. JOURNAL OF CLINICAL ONCOLOGY
- Loss of ATRX or DAXX expression and concomitant acquisition of the alternative lengthening of telomeres phenotype are late events in a small subset of MEN-1 syndrome pancreatic neuroendocrine tumors
- (2012) Roeland F de Wilde et al. MODERN PATHOLOGY
- Well-differentiated pancreatic neuroendocrine tumors: from genetics to therapy
- (2012) Roeland F. de Wilde et al. Nature Reviews Gastroenterology & Hepatology
- Profiling mTOR pathway in neuroendocrine tumors
- (2012) S. Cingarlini et al. Targeted Oncology
- ALK1 as an emerging target for antiangiogenic therapy of cancer
- (2011) S. I. Cunha et al. BLOOD
- Pericytes promote endothelial cell survival through induction of autocrine VEGF-A signaling and Bcl-w expression
- (2011) M. Franco et al. BLOOD
- Use of a Mouse Model of Pancreatic Neuroendocrine Tumors to Find Pericyte Biomarkers of Resistance to Anti-angiogenic Therapy
- (2011) M. Franco et al. HORMONE AND METABOLIC RESEARCH
- Chromogranin A and Neuron-Specific Enolase as Prognostic Markers in Patients with Advanced pNET Treated with Everolimus
- (2011) James C. Yao et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 study
- (2011) Marianne E Pavel et al. LANCET
- Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors
- (2011) Eric Raymond et al. NEW ENGLAND JOURNAL OF MEDICINE
- Everolimus for Advanced Pancreatic Neuroendocrine Tumors
- (2011) James C. Yao et al. NEW ENGLAND JOURNAL OF MEDICINE
- Altered Telomeres in Tumors with ATRX and DAXX Mutations
- (2011) C. M. Heaphy et al. SCIENCE
- A Shining Light in the Darkness for the Treatment of Pancreatic Neuroendocrine Tumors
- (2011) J. Capdevila et al. Cancer Discovery
- 18F-Fluorodeoxyglucose Positron Emission Tomography Predicts Survival of Patients with Neuroendocrine Tumors
- (2010) T. Binderup et al. CLINICAL CANCER RESEARCH
- MEN1 in pancreatic endocrine tumors: analysis of gene and protein status in 169 sporadic neoplasms reveals alterations in the vast majority of cases
- (2010) Vincenzo Corbo et al. ENDOCRINE-RELATED CANCER
- Hallmarks of cancer: Interactions with the tumor stroma
- (2010) Kristian Pietras et al. EXPERIMENTAL CELL RESEARCH
- A Potential Inhibitory Role for the New Truncated Variant of Somatostatin Receptor 5, sst5TMD4, in Pituitary Adenomas Poorly Responsive to Somatostatin Analogs
- (2010) Mario Durán-Prado et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Survival Benefit With Proapoptotic Molecular and Pathologic Responses From Dual Targeting of Mammalian Target of Rapamycin and Epidermal Growth Factor Receptor in a Preclinical Model of Pancreatic Neuroendocrine Carcinogenesis
- (2010) Christopher W. Chiu et al. JOURNAL OF CLINICAL ONCOLOGY
- Genetic and pharmacological targeting of activin receptor-like kinase 1 impairs tumor growth and angiogenesis
- (2010) Sara I. Cunha et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Activity of a multitargeted chemo-switch regimen (sorafenib, gemcitabine, and metronomic capecitabine) in metastatic renal-cell carcinoma: a phase 2 study (SOGUG-02-06)
- (2010) Joaquim Bellmunt et al. LANCET ONCOLOGY
- Distant metastasis occurs late during the genetic evolution of pancreatic cancer
- (2010) Shinichi Yachida et al. NATURE
- A Nomogram to Assess Small-Intestinal Neuroendocrine Tumor (‘Carcinoid’) Survival
- (2010) Irvin M. Modlin et al. NEUROENDOCRINOLOGY
- Paraneoplastic Antigen Ma2 Autoantibodies as Specific Blood Biomarkers for Detection of Early Recurrence of Small Intestine Neuroendocrine Tumors
- (2010) Tao Cui et al. PLoS One
- The ENETS and AJCC/UICC TNM classifications of the neuroendocrine tumors of the gastrointestinal tract and the pancreas: a statement
- (2010) Günter Klöppel et al. VIRCHOWS ARCHIV
- Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis
- (2009) Marta Pàez-Ribes et al. CANCER CELL
- Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group
- (2009) Anja Rinke et al. JOURNAL OF CLINICAL ONCOLOGY
- Pancreatic Endocrine Tumors: Expression Profiling Evidences a Role for AKT-mTOR Pathway
- (2009) Edoardo Missiaglia et al. JOURNAL OF CLINICAL ONCOLOGY
- Daily Oral Everolimus Activity in Patients With Metastatic Pancreatic Neuroendocrine Tumors After Failure of Cytotoxic Chemotherapy: A Phase II Trial
- (2009) James C. Yao et al. JOURNAL OF CLINICAL ONCOLOGY
- Development of the Norfolk Quality of Life Tool for Assessing Patients With Neuroendocrine Tumors
- (2009) Etta Vinik et al. PANCREAS
- O6-Methylguanine DNA Methyltransferase Deficiency and Response to Temozolomide-Based Therapy in Patients with Neuroendocrine Tumors
- (2008) M. H. Kulke et al. CLINICAL CANCER RESEARCH
- Targeting Vascular Endothelial Growth Factor in Advanced Carcinoid Tumor: A Random Assignment Phase II Study of Depot Octreotide With Bevacizumab and Pegylated Interferon Alfa-2b
- (2008) James C. Yao et al. JOURNAL OF CLINICAL ONCOLOGY
- Efficacy of RAD001 (Everolimus) and Octreotide LAR in Advanced Low- to Intermediate-Grade Neuroendocrine Tumors: Results of a Phase II Study
- (2008) James C. Yao et al. JOURNAL OF CLINICAL ONCOLOGY
- Gastroenteropancreatic neuroendocrine tumours
- (2008) Irvin M Modlin et al. LANCET ONCOLOGY
- Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
- (2008) S. Jones et al. SCIENCE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started